International Assets Investment Management LLC Makes New Investment in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

International Assets Investment Management LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 60,880 shares of the company’s stock, valued at approximately $4,633,000. International Assets Investment Management LLC owned 1.61% of Invesco Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Modera Wealth Management LLC purchased a new position in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth approximately $538,000. Commonwealth Retirement Investments LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter valued at approximately $1,557,000. Cambridge Investment Research Advisors Inc. boosted its stake in Invesco Pharmaceuticals ETF by 206.0% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 41,273 shares of the company’s stock valued at $2,987,000 after purchasing an additional 27,786 shares during the last quarter. Finally, UBS Group AG raised its stake in shares of Invesco Pharmaceuticals ETF by 132.2% in the third quarter. UBS Group AG now owns 92,123 shares of the company’s stock worth $6,667,000 after purchasing an additional 52,455 shares during the last quarter.

Invesco Pharmaceuticals ETF Price Performance

Invesco Pharmaceuticals ETF stock opened at $79.69 on Thursday. Invesco Pharmaceuticals ETF has a one year low of $67.75 and a one year high of $80.65. The business’s fifty day moving average is $78.02 and its 200 day moving average is $75.39. The stock has a market capitalization of $274.93 million, a PE ratio of 20.25 and a beta of 0.64.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.